Breaking News Instant updates and real-time market news.

DAL

Delta Air Lines

$53.33

0.215 (0.40%)

, BA

Boeing

$261.98

0.07 (0.03%)

11:04
10/13/17
10/13
11:04
10/13/17
11:04

Virgin gives London-NYC flight to Delta as 787s need engine fix, Bloomberg says

Virgin Atlantic has transferred a trans-Atlantic flight to Delta (DAL) so that some of its own Boeing (BA) 787 Dreamliner jets can be grounded for engine repair, Bloomberg reports. Delta took over the London Heathrow-New York JFK service Thursday and plans to operate it until October 31 using older Boeing 767s and maybe 777s, the report notes. The move will allow Rolls-Royce Holdings (RYCEY) Trent 1000 turbines that power Virgin's 787s to get fixed, the report says, citing Craig Kreeger, Virgin Atlantic's CEO. "It's a substitution that gives us a little bit more resilience as we've had some parts issues with our 787 engines," Kreeger said. "This ensures that we'll have sufficient capacity. It's circumstantial, it's not a strategy." Reference Link

DAL

Delta Air Lines

$53.33

0.215 (0.40%)

BA

Boeing

$261.98

0.07 (0.03%)

RYCEY

Rolls-Royce

$12.18

0.15 (1.25%)

  • 25

    Oct

  • 01

    Nov

DAL Delta Air Lines
$53.33

0.215 (0.40%)

10/12/17
10/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delta Air Lines (DAL) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying the company is likely to grow unit revenues in fiscal year 2018 due to pricing power in its key domestic hubs and improving international results. 2. Transocean (RIG) upgraded to Buy from Neutral at Citi with analyst Scott Gruber saying if an upturn is forthcoming, Transocean should outperform given a "diminution" of concern toward its balance sheet and more new contract catalysts. 3. Canadian Pacific (CP) upgraded to Overweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he sees a shift to stronger volume growth as the company laps contract losses and records some new contract wins. 4. Infinity upgraded to Outperform from Market Perform at Wells Fargo with analyst Jim Birchenough saying the IPI-549 monotherapy data have a "reasonable likelihood" of proof-of-concept response rate, and with likely validation of tumor macrophage targeting in immunooncology and a unique mechanism of action, upside potential is not reflected in the current stock price. 5. Kroger (KR) upgraded to Equal Weight from Underweight at Stephens with analyst Ben Bienvenu saying he believes the pursuit of strategic alternatives for the convenience store business has potential to unlock value and that the risk/reward is more balanced following the stock's recent pullback. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/17
IMPC
10/12/17
UPGRADE
Target $63
IMPC
Outperform
Delta Air Lines upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Michael Derchin upgraded Delta Air Lines to Outperform and raised his price target for the shares to $63 from $50. The company is likely to grow unit revenues in fiscal year 2018 due to pricing power in its key domestic hubs and improving international results, the analyst tells investors in a research note.
10/06/17
DBAB
10/06/17
DOWNGRADE
Target $38
DBAB
Hold
Spirit Airlines downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Michael Linenberg downgraded Spirit Airlines (SAVE) to Hold and lowered his price target for the shares to $38 from $42. The company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets, Linenberg tells investors in a research note previewing September quarter earnings for Airlines. His favorite names in the sector are Delta Air Lines (DAL), American Airlines (AAL) and Southwest (LUV).
10/03/17
JPMS
10/03/17
NO CHANGE
JPMS
Delta Air Lines estimates lowered on Hurricane Irma impact, says JPMorgan
JPMorgan analyst Jamie Baker lowered his Q3 EPS estimate for Delta Air Lines (DAL) to $1.52 from $1.60 after the company lowered its Q3 operating margin guidance, given the impact of Hurricane Irma. Despite the downward revision, Baker maintained an Overweight rating and $63 price target on Delta shares. Baker also noted that American Airlines (AAL) was likely to guide down as well, as American has a higher percentage of capacity traveling through Florida than Delta, 15.7% to 12.7%, respectively.
BA Boeing
$261.98

0.07 (0.03%)

10/13/17
DBAB
10/13/17
NO CHANGE
DBAB
Deutsche Bank likes three Defense names into Q3 results
Ahead of the Aerospace & Defense earnings season which begins on October 18, Deutsche Bank analyst Myles Walton says he likes Boeing (BA), Huntington Ingalls (HII) and Raytheon (RTN) into the reports. Helping support the quarter was continued strong air traffic demand, inflecting defense spending outlays, and the increasing geopolitical threat environment, Walton tells investors in a research previewing the earnings for the sector. The analyst increased some price targets in the space, including Huntington Ingalls to $260 from $240, Barnes Group (B) to $77 from $70, Hexcel (HXL) to $66 from $60 and Spirit AeroSystems (SPR) to $83 from $75.
10/09/17
RBCM
10/09/17
NO CHANGE
Target $209
RBCM
Outperform
Defense and Aerospace sector poised for strong Q3, says RBC Capital
RBC Capital analyst Matthew McConnell previewed the Q3 earnings season for the defense and commercial aviation industries, raising price targets across the sectors. In defense, McConnell likes the companies with focus on international markets, where demand has not yet been reflected in orders or backlog. Among his favorites, McConnell raises the price target on Raytheon (RTN) to $209 from $193, General Dynamics (GD) to $241 from $220, Northrop Grumman (NOC) to $324 from $294, Lockheed Martin (LMT) to $327 from $289, and Triumph (TGI) to $38 from $33. He also states that there may be room for some consolidation in defense given that budget up-cycle is only 2 years old, profiling Astronics (ATRO), Barnes (B), Esterline (ESL), Heico (HEI), and Textron (TXT) as some of the potential targets. In commercial aviation, McConnell sees Boeing (BA) upside driven by continued strong air traffic growth, mature sales campaigns, and expectations for a strong wide-body replacement cycle starting in the early 2020s, raising his price target on Boeing to $269 from $235.
10/09/17
BARD
10/09/17
NO CHANGE
Target $325
BARD
Outperform
Boeing upside remains despite year-to-date run, says Baird
Baird analyst Peter Arment said he continues to see upside in Boeing shares despite its 66% run year-to-date. The analyst said the year's move is a reflection of the company's ongoing execution, robust free cash flow generation, and the emerging new leg of growth with BGS. Arment tells investors to stay long and he reiterated his Outperform rating and $325 price target on Boeing shares.
10/06/17
ADAM
10/06/17
NO CHANGE
Target $235
ADAM
Hold
Boeing acquisition leverages defense and commercial business, says Canaccord
Canaccord analyst Ken Herbert noted Boeing announced it agreed to acquire Aurora Flight Sciences, which allows it to gain access to leading technology in both its military and commercial platforms. The deal will have limited financial impact, but it will give Boeing the opportunity to be at the forefront of autonomous innovation, said Herbert, who maintained his Hold rating and $235 price target on Boeing shares.
RYCEY Rolls-Royce
$12.18

0.15 (1.25%)

02/01/17
UBSW
02/01/17
UPGRADE
UBSW
Buy
Rolls-Royce upgraded to Buy from Neutral at UBS
Price target 835p.

TODAY'S FREE FLY STORIES

AAOI

Applied Optoelectronics

$42.29

-1.45 (-3.32%)

, XME

SPDR S&P Metals & Mining

$32.73

0.15 (0.46%)

08:45
10/19/17
10/19
08:45
10/19/17
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AAOI

Applied Optoelectronics

$42.29

-1.45 (-3.32%)

XME

SPDR S&P Metals & Mining

$32.73

0.15 (0.46%)

CBI

CB&I

$15.85

-0.19 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 16

    Nov

08:45
10/19/17
10/19
08:45
10/19/17
08:45
General news
Treasury Action: yields stabilized above lows »

Treasury Action: yields…

HRL

Hormel Foods

$31.34

-0.17 (-0.54%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Recommendations
Hormel Foods analyst commentary  »

Hormel Foods price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$159.76

-0.71 (-0.44%)

, HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Periodicals
Apple, suppliers fall after report of reduced iPhone 8 orders, Bloomberg says »

Shares of Apple (AAPL)…

AAPL

Apple

$159.76

-0.71 (-0.44%)

HNHPF

Hon Hai Precision

$7.49

0.412 (5.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

GALT

Galectin Therapeutics

$2.51

0.22 (9.61%)

08:44
10/19/17
10/19
08:44
10/19/17
08:44
Initiation
Galectin Therapeutics initiated  »

Galectin Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$47.52

0.51 (1.08%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

RMBL

RumbleON

$9.30

0.3 (3.33%)

08:42
10/19/17
10/19
08:42
10/19/17
08:42
Syndicate
RumbleON 2.91M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

XPO

XPO Logistics

$64.76

0.12 (0.19%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Hot Stocks
Department of Defense boosts XPO contract by $139.5M to $2.32B »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

GEMP

Gemphire Therapeutics

$9.54

-0.08 (-0.83%)

08:40
10/19/17
10/19
08:40
10/19/17
08:40
Initiation
Gemphire Therapeutics initiated  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$37.97

0.48 (1.28%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Recommendations
eBay analyst commentary  »

eBay progress…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:39
10/19/17
10/19
08:39
10/19/17
08:39
Hot Stocks
Genuine Parts announces two industrial and automotive acquisitions »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

BANR

Banner Corp.

$61.29

0.54 (0.89%)

, PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

08:38
10/19/17
10/19
08:38
10/19/17
08:38
Conference/Events
People's Utah Bancorp to hold a conference call »

Management discusses…

BANR

Banner Corp.

$61.29

0.54 (0.89%)

PUB

People's Utah Bancorp

$32.85

0.2 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 26

    Oct

  • 09

    Nov

MTG

MGIC Investment

$13.54

0.43 (3.28%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
MGIC Investment analyst commentary  »

MGIC Investment price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$153.00

2.62 (1.74%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

IFMK

iFresh

$12.15

-0.1 (-0.82%)

08:37
10/19/17
10/19
08:37
10/19/17
08:37
Hot Stocks
iFresh announces exclusive agreement with Dragon Seeds »

iFresh announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$7.00

-0.05 (-0.71%)

08:36
10/19/17
10/19
08:36
10/19/17
08:36
Technical Analysis
Technical View: Corbus Pharmaceuticals surges on anabasum Phase 2 results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$12.33

0.01 (0.08%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Hot Stocks
Celestica appoints Mandeep Chawla as CFO »

Celestica announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Hot Stocks
Genuine Parts CEO: Q3 'presented us with both opportunities and challenges' »

Paul Donahue, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

AXP

American Express

$92.08

0.39 (0.43%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Recommendations
American Express analyst commentary  »

American Express guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 08

    Nov

AXP

American Express

$92.08

0.39 (0.43%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 08

    Nov

AGEN

Agenus

$4.71

0.04 (0.86%)

, ADRO

Aduro Biotech

$9.55

-0.1 (-1.04%)

08:35
10/19/17
10/19
08:35
10/19/17
08:35
Conference/Events
William Blair biotech analyst holds an analyst/industry conference call Aduro Biotech »

Biotech Analyst Phipps,…

AGEN

Agenus

$4.71

0.04 (0.86%)

ADRO

Aduro Biotech

$9.55

-0.1 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 24

    Oct

ARNA

Arena Pharmaceuticals

$27.56

0.71 (2.64%)

08:34
10/19/17
10/19
08:34
10/19/17
08:34
Hot Stocks
Arena Pharmaceuticals reports Phase 2 results of ralinepag in hypertension »

Arena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VCYT

Veracyte

$9.19

0.29 (3.26%)

08:33
10/19/17
10/19
08:33
10/19/17
08:33
Hot Stocks
Veracyte to present data on Percepta Bronchial Genomic Classifier at CHEST 2017 »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$98.04

1.18 (1.22%)

08:32
10/19/17
10/19
08:32
10/19/17
08:32
Earnings
Genuine Parts cuts FY17 adjusted EPS view to $4.55-$4.60 from $4.70-$4.75 »

FY17 consensus $4.73.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 30

    Oct

08:32
10/19/17
10/19
08:32
10/19/17
08:32
General news
Jobless Claims data reported »

Week of 10/14 Jobless…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.